-
1دورية أكاديمية
المؤلفون: Pablo Frias, Juan1, Nauck, Michael A.2, Van, Joanna3, Kutner, Mark E.4, Xuewei Cui5, Benson, Charles5, Urva, Shweta5, Gimeno, Ruth E.5, Milicevic, Zvonko6, Robins, Deborah5, Haupt, Axel5 haupt_axel@lilly.com, Frias, Juan Pablo7, Cui, Xuewei8
المصدر: Lancet. 11/17/2018, Vol. 392 Issue 10160, p2180-2193. 14p.
مصطلحات موضوعية: *RESEARCH, *STATISTICAL sampling, GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide 1, TYPE 2 diabetes treatment, DRUG efficacy, GLYCOSYLATED hemoglobin, BLOOD sugar, COMPARATIVE studies, DRUG administration, HYPOGLYCEMIC agents, IMMUNOGLOBULINS, RESEARCH methodology, MEDICAL cooperation, TYPE 2 diabetes, RECOMBINANT proteins, WEIGHT loss, EVALUATION research, RANDOMIZED controlled trials, TREATMENT effectiveness, BLIND experiment, GLUCAGON-like peptides
-
2دورية أكاديمية
المؤلفون: Harmony Outcomes committees and investigators, Hernandez, Adrian F.1, Green, Jennifer B.1, Granger, Christopher B.1, Rosenberg, Anne E.1, Sigmon, Kristina N.1, Janmohamed, Salim2, Jones, Nigel P.2, Thorpe, Karl M.2, D'Agostino Sr., Ralph B.3, Leiter, Lawrence A.4, Somerville, Matthew C.5, McMurray, John J. V.6, Del Prato, Stefano7, D'Agostino, Ralph B Sr8
المصدر: Lancet. 10/27/2018, Vol. 392 Issue 10157, p1519-1529. 11p.
مصطلحات موضوعية: GLUCAGON-like peptide-1 receptor, TYPE 2 diabetes risk factors, CARDIOVASCULAR disease prevention, CARDIOVASCULAR diseases risk factors, MYOCARDIAL infarction risk factors, SODIUM-glucose cotransporters, TYPE 2 diabetes complications, STROKE prevention, SUBCUTANEOUS injections, CARDIOVASCULAR diseases, COMPARATIVE studies, DRUG administration, HYPOGLYCEMIC agents, MYOCARDIAL infarction, TYPE 2 diabetes, STROKE, GLUCAGON-like peptide 1, RANDOMIZED controlled trials, TREATMENT effectiveness, BLIND experiment, KAPLAN-Meier estimator, PREVENTION, THERAPEUTICS
-
3دورية أكاديمية
المؤلفون: Holst, Jens Juul1 (AUTHOR) jjholst@sund.ku.dk
المصدر: Lancet. Jul2019, Vol. 394 Issue 10192, p4-6. 3p.
مصطلحات موضوعية: GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, TYPE 2 diabetes
-
4دورية أكاديمية
المؤلفون: Mafham, Marion1, Preiss, David1
المصدر: Lancet. 10/27/2018, Vol. 392 Issue 10157, p1489-1490. 2p.
مصطلحات موضوعية: GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, CARDIOVASCULAR disease treatment
الشركة/الكيان: GLAXOSMITHKLINE
People: HERNANDEZ, Adrian
-
5دورية أكاديمية
المؤلفون: Madsbad, Sten1 sten.madsbad@hvh.regionh.dk
المصدر: Lancet. 6/16/2012, Vol. 379 Issue 9833, p2222-2223. 2p.
مصطلحات موضوعية: GLUCAGON-like peptide-1 receptor, TYPE 2 diabetes, INSULIN, HYPERTENSION, HEART diseases, GLUCAGON
-
6دورية أكاديمية
المؤلفون: Evans, Mark L, Golubic, Rajna
مصطلحات موضوعية: Algorithms, Biomedical Technology, Blood Glucose, Diabetes Mellitus, Type 2, Drug Delivery Systems, Female, Glucagon-Like Peptide-1 Receptor, Glycated Hemoglobin, Humans, Insulin, Male, Physicians, Primary Care, Treatment Outcome
وصف الملف: Print-Electronic; application/octet-stream
الإتاحة: https://doi.org/10.17863/CAM.40479Test
https://www.repository.cam.ac.uk/handle/1810/293325Test -
7دورية أكاديمية
المؤلفون: Garvey, W Timothy1 (AUTHOR) garveyt@uab.edu, Frias, Juan P2 (AUTHOR), Jastreboff, Ania M3 (AUTHOR), le Roux, Carel W4,5 (AUTHOR), Sattar, Naveed6 (AUTHOR), Aizenberg, Diego7 (AUTHOR), Mao, Huzhang8 (AUTHOR), Zhang, Shuyu8 (AUTHOR), Ahmad, Nadia N8 (AUTHOR), Bunck, Mathijs C8 (AUTHOR), Benabbad, Imane8 (AUTHOR), Zhang, Xiaotian M8 (AUTHOR)
المصدر: Lancet. Aug2023, Vol. 402 Issue 10402, p613-626. 14p.
مصطلحات موضوعية: TYPE 2 diabetes, CLINICAL trials, GLUCAGON-like peptide-1 receptor, TERMINATION of treatment, WEIGHT loss
الشركة/الكيان: ELI Lilly & Co. LLY
-
8دورية أكاديمية
المؤلفون: Diamant, Michaela1 m.diamant@vumc.nl
المصدر: Lancet. 6/16/2012, Vol. 379 Issue 9833, p2220-2221. 2p.
مصطلحات موضوعية: METFORMIN, TREATMENT of diabetes, BLOOD sugar, GLUCAGON-like peptide-1 receptor, INSULIN, WEIGHT gain
-
9دورية أكاديمية
المؤلفون: Rayner, Christopher K.1,2, Horowitz, Michael1,3
المصدر: Lancet. 6/30/2018, Vol. 391 Issue 10140, p2577-2578. 2p. 1 Color Photograph.
مصطلحات موضوعية: *PEPTIDE hormones, *TYPE 2 diabetes, *BARIATRIC surgery, *GLUCAGON, *GLUCAGON-like peptide-1 receptor, *PANCREAS